Osmotica Pharmaceuticals Plc

OSMT NASDAQ
3.620
+0.020
+0.56%
Closed 16:00 07/18 EDT
Open
3.580
Prev Close
3.600
High
3.660
Low
3.565
Volume
42.02K
Avg Vol (3M)
197.28K
52 Week High
9.90
52 Week Low
2.200
% Turnover
0.08%
Market Cap
185.19M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Osmotica Pharmaceuticals Plc OSMT stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Osmotica Pharmaceuticals plc is an integrated biopharmaceutical company. The Company is focused on the developing and commercialization of specialty products that target markets with underserved patient populations. The Company is focused on progressing Phase III candidates under clinical development Ontinua ER and RVL-1201. It has developed Ontinua ER using its proprietary Osmodex drug delivery system. Ontinua ER has been designated by the FDA as an Orphan Drug in this indication. The Company is conducting a second Phase III clinical trial of RVL-1201 for droopy eyelid. The Company’s promoted products include specialty neurology drugs, such as Lorzone and ConZip for pain management, as well as women's health products, such as Divigel for menopause and the OB Complete family of prescription prenatal dietary supplements. The Company’s non-promoted products portfolio include methylphenidate ER and VERT as well as smaller volume ANDAs and prescription dietary supplements.
MORE >

Recently

Name
Price
%Change